Matt Plavan has served as Interim CEO since May 2026 and as Origin's Chief Financial Officer since November 2023. Mr. Plavan brings 30 years of successful leadership and board governance experience in public and privately held companies within the ag-tech, medical device, cell therapy, and healthcare industries, and is recognized for an ability to identify and capitalize on new market opportunities and follow-through execution of enterprise-wide growth initiatives. Most recently, from May 2022 to October 2023, Mr. Plavan served as Chief Executive Officer of IngredientWerks, Inc., having led the company's founding spin-out from Agrivida, Inc. and initial seed financing to launch a leading molecular farming company specializing in the development of plant-based animal protein ingredients for the alternative protein and food ingredient markets. Prior to launching IngredientWerks, Mr. Plavan joined Arcadia Biosciences, Inc. (“Arcadia”) as Chief Financial Officer in September 2016 and served as President and Chief Executive Officer from September 2018 to December 2021, successfully leading Arcadia through the transition from an agricultural biotechnology trailblazer to a dynamic revenue generating consumer food products company targeting on-trend wellness and wheat-based ingredient categories with disruptive nutrition density. Prior to joining Arcadia, Mr. Plavan spent a decade with Cesca Therapeutics, Inc. (formerly known as ThermoGenesis Corp), his latest role serving as Chief Executive Officer and board member, successfully leading a transformational pivot from a medical device manufacturer to a high-value stem cell therapy company. As a Chief Financial Officer, Mr. Plavan also led the finances of two high-tech private equity backed companies, StrionAir Inc. and Reason, Inc., positioning each for successful exits. Previously, Mr. Plavan spent a half dozen years with McKesson Corporation, the oldest and largest healthcare company in the U.S., his latest role serving as Vice President of Finance for the health care information services division, iMcKesson. Mr. Plavan began his career with a six-year tenure at Ernst & Young, LLC. Mr. Plavan is an inactive certified public accountant and earned a bachelor’s degree in business economics from the University of California, Santa Barbara.
What is Matthew T. Plavan's net worth?
The estimated net worth of Matthew T. Plavan is at least $41.43 thousand as of January 16th, 2026. Mr. Plavan owns 43,607 shares of Origin Materials stock worth more than $41,431 as of October 8th. This net worth evaluation does not reflect any other investments that Mr. Plavan may own. Learn More about Matthew T. Plavan's net worth.
How do I contact Matthew T. Plavan?
Has Matthew T. Plavan been buying or selling shares of Origin Materials?
Matthew T. Plavan has not been actively trading shares of Origin Materials within the last three months. Most recently, Matthew T. Plavan sold 400 shares of the business's stock in a transaction on Friday, January 16th. The shares were sold at an average price of $6.00, for a transaction totalling $2,400.00. Following the completion of the sale, the chief financial officer now directly owns 43,607 shares of the company's stock, valued at $261,642. Learn More on Matthew T. Plavan's trading history.
Who are Origin Materials' active insiders?
Are insiders buying or selling shares of Origin Materials?
In the last year, insiders at the financial services provider sold shares 8 times. They sold a total of 12,637 shares worth more than $135,650.10. The most recent insider tranaction occured on January, 16th when CFO
Matthew T. Plavan sold 400 shares worth more than $2,400.00. Insiders at Origin Materials own 2.8% of the company.
Learn More about insider trades at Origin Materials. Information on this page was last updated on 1/16/2026.
